Health in Grenada 1,301 indicators covering health for Grenada. IndicatorLatest Year10-yr change Rank Percentage of total deaths due to NCDs overall and percentage of 36.97 2021 up 231.9% 49th Total official development assistance to medical research and basic 0.527 2024 up 2,946.3% 134th Pharmacists 6.52 2016 up 229.3% 58th Import of environmentally sound technologies 35.62 million usd 2024 up 176.5% 168th Export of environmentally sound technologies 3.64 million usd 2024 up 108.5% 148th Inactivated first-dose polio vaccine (IPV1) immunization coverage 93.0% 2025 up 72.2% 98th 3.1.1 Maternal mortality ratio 21 2020 down 23.2% 119th New leprosy case detection rate per 1 000 000 population 0 2025 — 134th Death rate due to road traffic injuries 8 per 100,000 population 2019 up 42.9% 137th New or unknown treatment history cases: Pulmonary, bacteriologically 4 2023 — 186th Medical doctors not further defined 160 2018 up 100.0% 121st Leprosy registered prevalence rate per 1 000 000 population 0 2025 — 133rd Leprosy - Number of cases registered for treatment 0 2025 down 100.0% 133rd Leprosy - Number of new leprosy cases among children 0 2025 — 77th New leprosy child case detection rate (less than 15 years of age) per 0 2025 — 77th Constant stillbirth rate 9.46 2030 unchanged 78th ENAP target met stillbirth rate 9.32 2030 down 1.2% 72nd Stillbirth rate high-income country 2.8 2030 down 64.8% 1st Stillbirths remain constant projection 12 2030 down 7.7% 181st Stillbirth maintained projection 12 2030 down 7.7% 180th Stillbirth ENAP 2030 target met projection 12 2030 down 7.7% 180th Stillbirth high-income country average rate matched projection 3 2030 down 72.7% 183rd Stillbirth rate current trends 9.32 2030 down 1.2% 72nd Life satisfaction vs. life expectancy 75.2 years 2023 up 0.2% 120th Number of female leprosy new cases 0 2025 — 115th Tuberculosis patients who tested positive for HIV 0 patients 2021 — 160th Number of children aged 6-59 months with anaemia 2.14 2019 up 1.8% 179th Prevalence of anaemia in children aged 6-59 months 23.6% 2019 down 1.7% 114th Mean hemoglobin level of children aged 6-59 months 119 2019 up 0.8% 59th Neonatal mortality rate - Remains constant 12.3 2030 unchanged 73rd Neonatal mortality rate - Current trends maintained 12.3 2030 unchanged 66th Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 70.9% 1st Neonatal mortality rate - SDG target met 12 2030 down 2.0% 1st Under 5 mortality rate - Remains constant 17.96 2030 unchanged 79th Under 5 mortality rate - Current trends maintained 17.76 2030 down 0.9% 73rd Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 64.8% 1st Under 5 mortality rate - SDG target met 17.46 2030 down 2.3% 73rd Mortality rate age 10-19 - Remains constant 4.66 2030 down 4.4% 105th Mortality rate age 10-19 - Current trends maintained 4.66 2030 down 4.4% 96th Mortality rate age 10-19 - High-income country average rate matched 2.03 2030 down 49.2% 152nd Neonatal deaths - Remains constant 15 2030 down 6.2% 176th Neonatal deaths - Current trends maintained 15 2030 down 6.2% 174th Neonatal deaths - SDG target met 15 2030 down 6.2% 173rd Under-five deaths - Remains constant 22 2030 down 8.3% 178th Under-five deaths - Current trends maintained 22 2030 down 8.3% 177th Under-five deaths - SDG target met 22 2030 down 8.3% 176th Deaths age 10 to 19 - Remains constant 7 2030 down 22.2% 182nd Deaths age 10 to 19 - Current trends maintained 7 2030 down 22.2% 181st Number of deaths attributed to non-communicable diseases, by type of 207.04 2019 down 1.4% 173rd Hepatitis B surface antigen (HBsAg) prevalence 0.2% 2024 down 50.0% 82nd Mortality caused by road traffic injury 8 per 100,000 population 2019 up 110.5% 138th Mortality caused by road traffic injury, female 0.9 per 100,000 female population 2019 up 50.0% 177th Mortality caused by road traffic injury, male 14.9 per 100,000 male population 2019 up 115.9% 124th Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd Number of new G2D leprosy cases 0 2025 — 93rd Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2025 — 93rd Share of one-year-olds who received the inactivated polio vaccine 93.0% 2024 up 72.2% 98th HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2019 unchanged 1st Tuberculosis patients living with HIV receiving antiretroviral therapy 0 patients 2021 — 141st Hospital beds 30.06 2023 down 15.5% 61st ← Previous Page 20 of 22 Next →